Avista Pharma Solutions, a Durham, North Carolina-headquartered contract testing, development, and manufacturing organization, has completed the expansion and upgrade of its analytical laboratories at its Durham facility.

Comprised of two laboratories, the analytical research and development and quality control labs have now doubled in size with expanded service offerings. 

Avista’s offering now includes: (1) chromatographic method development for assay and related substances, potential genotoxic impurities, organic volatile impurities and residual solvents; (2) spectral identification using upgraded fourier transform infrared spectroscopy, nuclear magnetic resonance (NMR) and ultraviolet–visible spectroscopy instrumentation;(3) structural chemistry and impurity identification through mass liquid chromatography–mass spectrometry and generation fragmentation, 1D and 2D NMR and preparative chromatography isolation;(4) fate and purge studies; (5) extractable/leachable studies; and (6) release and stability testing.

Source: Avista Pharma Solutions